Featured insights The latest at the Foundation Insights from our industry-shifting research and analysis, coverage in the international media, events, and all the latest from the Access to Medicine Foundation. Media Poor countries desperately need better access to generic medicines 15 February 2023 Media Here's how we can get better access to sexual and reproductive health to women around the world 02 February 2023 News Index finds more pharma companies moving to address access to medicine. Will they now go further? 15 November 2022 Featured News First-of-its-kind framework to assess how generics manufacturers expand access to medicine 15 February 2023 Resource Center Explore our research reports and publications Featured Key findings Some companies engaging in R&D for emerging infectious diseases, but pipeline mainly empty 15 November 2022 Key findings More access plans and strategies to expand access to more products, but with limited breadth and depth 15 November 2022 Featured News Drugmakers that dominate the world's insulin market must scale up access efforts globally 06 October 2022 Research Implementing strong access strategies across different country income classifications 15 November 2022 2022 Ranking GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking. Read more News Drug makers must address access to antibiotics to help slow the superbug threat 09 June 2022 Event Impact Summit Europe 2023: Marijn Verhoef to moderate session on healthcare systems and equitable access 28 March 2023 Media Framework to assess, nudge generic drug makers to expand access to products 15 February 2023 Achievements so far Read more about the Foundation's impact Event Closing the gaps in access to diabetes care in low- and middle-income countries 07 July 2022 News Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries 16 June 2021